Unlocking Success in Obesity Clinical Trials: Mastering Patient Engagement and Retention
Are you a biotech leader striving to revolutionize obesity treatment? Discover how mastering patient engagement and retention can be the game-changer for your clinical trials.
With groundbreaking advancements in obesity care, including next-gen GLP-1s, the key to clinical success lies not just in innovation but in maintaining robust patient engagement and retention throughout complex trials. Without sustained patient engagement, even the most promising therapies risk delays, data loss, or failure to demonstrate meaningful benefit. Obesity clinical trials face unique challenges, particularly in long-duration, placebo-controlled studies, where perceived benefit, stigma, and access challenges converge to increase dropout risk.
In this candid and solutions-focused webinar, you will hear from leaders who bring both clinical and personal experience to the conversation. From mental health and “food noise” to site operations and decentralized trial design, our panelists will share practical insights on how to improve the patient experience and retain participants throughout the trial journey. You will gain strategies to enhance retention, lessen site burden, and support patients throughout the trial.
Related Insights
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Related Insights
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022